Literature DB >> 1998479

Effect of splenectomy on morbidity and survival following curative gastrectomy for carcinoma.

M S Brady1, A Rogatko, L L Dent, M H Shiu.   

Abstract

We performed a retrospective analysis of 392 patients who underwent curative resection of gastric adenocarcinoma to evaluate the impact of splenectomy on survival from gastric cancer and postoperative morbidity. Twelve factors, including splenectomy, were associated with a poor prognosis by univariate analysis. Multivariate analysis identified six of these factors, but not splenectomy, as independently predictive of death due to gastric cancer. The apparent adverse effect of splenectomy was due to its association with other significant risk factors. Postoperative complications occurred more commonly in patients who underwent splenectomy than in those who did not (45% vs 21%); patients in the splenectomy group also had a higher percentage of infectious complications than those in the nonsplenectomy group (75% vs 47%). We conclude that splenectomy has no direct influence on survival, but that it increases the morbidity of curative gastrectomy and should be avoided unless the spleen is close to or invaded by the tumor.

Entities:  

Mesh:

Year:  1991        PMID: 1998479     DOI: 10.1001/archsurg.1991.01410270105017

Source DB:  PubMed          Journal:  Arch Surg        ISSN: 0004-0010


  29 in total

1.  Obesity and postgastrectomy outcomes: large risks, fat chances, or no big deal?

Authors:  Roderich E Schwarz
Journal:  Gastric Cancer       Date:  2012-04       Impact factor: 7.370

2.  Multiorgan resection for gastric cancer: intraoperative and computed tomography assessment of locally advanced disease is inaccurate.

Authors:  Kari L Colen; Stuart G Marcus; Elliot Newman; Russell S Berman; Herman Yee; Spiros P Hiotis
Journal:  J Gastrointest Surg       Date:  2004-11       Impact factor: 3.452

3.  Subtotal or total gastrectomy for gastric cancer: impact of the surgical procedure on morbidity and prognosis--analysis of a 10-year experience.

Authors:  Ines Gockel; Sebastian Pietzka; Ursula Gönner; Gerhard Hommel; Theodor Junginger
Journal:  Langenbecks Arch Surg       Date:  2005-02-12       Impact factor: 3.445

4.  Appropriateness of splenectomy for advanced cancer located in the upper third of the stomach.

Authors:  Shinichi Sakuramoto; Keishi Yamashita; Masahiko Watanabe
Journal:  Surg Endosc       Date:  2010-05       Impact factor: 4.584

5.  Subtotal versus total gastrectomy for gastric cancer: five-year survival rates in a multicenter randomized Italian trial. Italian Gastrointestinal Tumor Study Group.

Authors:  F Bozzetti; E Marubini; G Bonfanti; R Miceli; C Piano; L Gennari
Journal:  Ann Surg       Date:  1999-08       Impact factor: 12.969

6.  Splenic hilar dissection in the treatment of proximal advanced gastric cancer: what is an adequate strategy?

Authors:  Takahiro Kinoshita
Journal:  Transl Gastroenterol Hepatol       Date:  2016-09-21

7.  Preoperative factors of prognostic significance in gastric cancer.

Authors:  H Johnson; C Belluco; S Masood; A Azama; L Kahn; L Wise
Journal:  J Natl Med Assoc       Date:  1995-06       Impact factor: 1.798

8.  Perspectives of surgery and multimodality treatment in gastric carcinoma.

Authors:  H J Meyer; J Jähne; H Wilke
Journal:  J Cancer Res Clin Oncol       Date:  1993       Impact factor: 4.553

9.  Extended local resection for advanced gastric cancer: increased survival versus increased morbidity.

Authors:  Robert C G Martin; David P Jaques; Murray F Brennan; Martin Karpeh
Journal:  Ann Surg       Date:  2002-08       Impact factor: 12.969

10.  Effectiveness and safety of splenectomy for gastric carcinoma: a meta-analysis.

Authors:  Kun Yang; Xin-Zu Chen; Jian-Kun Hu; Bo Zhang; Zhi-Xin Chen; Jia-Ping Chen
Journal:  World J Gastroenterol       Date:  2009-11-14       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.